about
Early injury of the neonatal lung contributes to premature lung aging: a hypothesisAberrant Pulmonary Vascular Growth and Remodeling in Bronchopulmonary DysplasiaThe Robyn Barst Memorial Lecture: Differences between the fetal, newborn, and adult pulmonary circulations: relevance for age-specific therapies (2013 Grover Conference series)Using Cell-Based Strategies to Break the Link between Bronchopulmonary Dysplasia and the Development of Chronic Lung Disease in Later LifeGene expression profiling in lung fibroblasts reveals new players in alveolarizationAssessment of pulmonary hypertension in the pediatric catheterization laboratory: current insights from the Magic registryRole of transabdominal ultrasound of lung bases and follow-up in premature neonates with respiratory distress soon after birthEffects of phosphodiesterase 4 inhibition on alveolarization and hyperoxia toxicity in newborn ratsLung volume, breathing pattern and ventilation inhomogeneity in preterm and term infants.Histologic Chorioamnionitis, Amniotic Fluid Interleukin 6, Krebs von den Lungen 6, and Transforming Growth Factor β1 for the Development of Neonatal Bronchopulmonary DysplasiaDiffuse Cystic Lung Disease. Part II.Prolonged mechanical ventilation induces cell cycle arrest in newborn rat lung.Disrupted lung development and bronchopulmonary dysplasia: opportunities for lung repair and regeneration.A comparison of KL-6 and Clara cell protein as markers for predicting bronchopulmonary dysplasia in preterm infantsMicroRNA-mRNA interactions in a murine model of hyperoxia-induced bronchopulmonary dysplasia.Claudin-18 deficiency results in alveolar barrier dysfunction and impaired alveologenesis in mice.The role of genetic polymorphisms in antioxidant enzymes and potential antioxidant therapies in neonatal lung diseaseGranulocyte colony stimulating factor attenuates hyperoxia-induced lung injury by down-modulating inflammatory responses in neonatal rats.Zfp148 deficiency causes lung maturation defects and lethality in newborn mice that are rescued by deletion of p53 or antioxidant treatment.Vascular mediators in chronic lung disease of infancy: role of endothelial monocyte activating polypeptide II (EMAP II).Computed tomography score and pulmonary function in infants with chronic lung disease of infancy.Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?Bronchopulmonary dysplasia early changes leading to long-term consequences.Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.L-citrulline attenuates arrested alveolar growth and pulmonary hypertension in oxygen-induced lung injury in newborn rats.Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.Elastase inhibitory activity of airway α1-antitrypsin is protected by treatment with a catalytic antioxidant in a baboon model of severe bronchopulmonary dysplasia.A risk factor analysis on disease severity in 47 premature infants with bronchopulmonary dysplasia.Systemic Hydrocortisone To Prevent Bronchopulmonary Dysplasia in preterm infants (the SToP-BPD study); a multicenter randomized placebo controlled trial.Long-term impact of bronchopulmonary dysplasia on pulmonary function.Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns.Vasculoprotective effects of heme oxygenase-1 in a murine model of hyperoxia-induced bronchopulmonary dysplasiaPhosphodiesterase 4 inhibition attenuates persistent heart and lung injury by neonatal hyperoxia in rats.Inhaled NO as a therapeutic agentGenetic associations of surfactant protein D and angiotensin-converting enzyme with lung disease in preterm neonates.Activation of the nuclear factor-κB pathway during postnatal lung inflammation preserves alveolarization by suppressing macrophage inflammatory protein-2.Exome Sequencing of Neonatal Blood Spots and the Identification of Genes Implicated in Bronchopulmonary DysplasiaDevelopment of a Model of Pediatric Lung Failure Pathophysiology.Point Prevalence, Clinical Characteristics, and Treatment Variation for Infants with Severe Bronchopulmonary Dysplasia.Evidence-Based Neonatal Unit Practices and Determinants of Postnatal Corticosteroid-Use in Preterm Births below 30 Weeks GA in Europe. A Population-Based Cohort Study.
P2860
Q26741052-570BE5B9-BDF6-4B81-A4C5-0AAE6520CEBEQ26744473-980CF412-0A99-4EB3-BA61-F327A6C8A991Q26862046-34B832A8-5B3C-4632-9CEB-A4FC7E733D5DQ28393759-91D60835-6C3E-4E58-825D-31545F3EA121Q28569682-2C79E70A-BAA0-423F-B560-318A4DA2CE92Q30429733-11A38EA7-7F56-4E2B-AD97-039F4D5C3982Q30452646-4D9822D9-7CFD-446A-816F-95C4D851E829Q33378441-A410AEF3-AF12-462B-B75D-3605FA18274AQ33413083-00363BBD-5521-4131-BCAC-3D02E9A01BCCQ33585146-91E34D42-20E5-4583-8CDF-126B784B2756Q33735622-91B16374-6E85-45A1-A942-8B0B7919BB50Q33832099-87AFCC6F-46EB-4A92-A18D-7FF09E21DD1BQ34003028-9D91DC9A-FFB8-434C-925B-69F4A6238B09Q34177127-1C52005E-6FC8-4DC1-97F7-19A88E7FAACEQ34286119-52D8936A-A169-4079-85E1-84F37E727FACQ34305526-6240D5AF-DA88-4925-BA1A-52C22F45DAAEQ34370825-7183C33A-A1E2-4BA7-BF80-1FFAA65CF851Q34474662-FA2076E8-A038-42ED-B62A-0F1837E71EBBQ34584445-295C9161-840A-46CE-BA58-2B1689E5A322Q34789755-685A3DB7-3F5D-47DF-A4B6-1F0BDE859A34Q34997381-7B7E07BE-1D98-41D2-844E-894689B5B36CQ35013615-1E943944-1EE1-4E80-8FDF-E5C056ACB6B2Q35077309-89D83955-5903-442C-9A10-91C8D3205051Q35086075-4E3A5F1C-6A17-4470-BF9A-96FA8A0D096BQ35093512-8B4FE0AB-3794-4A45-91B5-7DE0E53FBAA6Q35113434-2274BCF5-059A-4279-BE4B-A7B180E744CCQ35194438-F53D9FCF-49A4-4A32-965F-6F6F934BAB04Q35595943-87AB0D19-0B2F-4E08-9254-08B3BAD40797Q35632102-6159E927-C9D9-4515-B2A5-342162234912Q35703656-30F506D1-FC2F-42FF-A546-238AB125E98EQ35731694-8CAB817C-7B23-413D-9B90-F2E3774E42A4Q35902348-3900A759-93F1-4EEB-B383-164328CCB064Q35950168-0EB01270-944C-4059-B612-D9CA3C77579DQ36003322-399A540A-D737-4E7F-AA3B-60053A1B5334Q36017512-50FC6C4D-9CBF-45AA-95E4-168BD331E6F8Q36066479-64418516-D4BB-4C2A-94E0-F1DA074171EAQ36128616-D012DE8E-7F7A-4EEF-8C24-B611979265DDQ36188371-5D197DF1-B709-44F3-98D1-8D2AA9BD24C9Q36198883-9EF59401-CED0-452C-921B-8B0DF5B21C99Q36257620-10516276-5F6B-4BFE-8ED8-FAE5AAE1DFFF
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Bronchopulmonary dysplasia
@ast
Bronchopulmonary dysplasia
@en
Bronchopulmonary dysplasia
@nl
type
label
Bronchopulmonary dysplasia
@ast
Bronchopulmonary dysplasia
@en
Bronchopulmonary dysplasia
@nl
prefLabel
Bronchopulmonary dysplasia
@ast
Bronchopulmonary dysplasia
@en
Bronchopulmonary dysplasia
@nl
P3181
P1433
P1476
Bronchopulmonary dysplasia
@en
P2093
John P Kinsella
Steven H Abman
P304
P3181
P356
10.1016/S0140-6736(06)68615-7
P407
P577
2006-04-29T00:00:00Z